Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5465040 | 0.97 | ALDH1A1 (0.50) | ALDH1A1SLC18A3 | |
| SCHEMBL164544 | 0.97 | ALDH1A1 (0.57) | ALDH1A1 | |
| SCHEMBL1415394 | 0.88 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL386067 | 0.88 | ALDH1A1 (0.47) | ALDH1A1 | |
| SCHEMBL1132982 | 0.86 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL8922551 | 0.85 | ALDH1A1 (0.44) | ALDH1A1 | |
| SCHEMBL56058 | 0.84 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL11501635 | 0.84 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL8921838 | 0.84 | ALDH1A1 (0.50) | ALDH1A1 | |
| SCHEMBL8558475 | 0.84 | ALDH1A1 (0.50) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 428 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024094125-A1 | LIPID COMPOUNDS, LIPID NANOPARTICLES, AND PHARMACEUTICAL COMPOSITIONS | Shanghai Circode Biomed Co., Ltd. (CN) | 2024-05-10 | — | — | WO | claimed |
| US-20100152176-A1 | Modulators of Muscarinic Receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-06-17 | — | — | US | claimed |
| US-7696201-B2 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2010-04-13 | — | — | US | claimed |
| EP-2051712-A2 | MODULATORS OF MUSCARINIC RECEPTORS | Vertex Pharmceuticals Incorporated (US) | 2009-04-29 | — | — | EP | claimed |
| US-20080176843-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2008-07-24 | — | — | US | claimed |
| WO-2008021375-A2 | MODULATORS OF MUSCARINIC RECEPTORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-02-21 | — | — | WO | claimed |
| EP-1817032-A2 | MODULATORS OF MUSCARINIC RECEPTORS | Vertex Pharmaceuticals Incorporated (US) | 2007-08-15 | — | — | EP | claimed |
| US-20070089604-A1 | Novel chromatographic stationary phase | AGILENT TECHNOLOGIES, INC. | 2007-04-26 | — | — | US | claimed |
| US-20070090052-A1 | Chromatographic stationary phase | AGILENT TECHNOLOGIES, INC. | 2007-04-26 | — | — | US | claimed |
| US-20060287303-A1 | Modulators of muscarinic receptors | VERTEX PHARMACEUTICALS INCORPORATED | 2006-12-21 | — | — | US | claimed |
| EP-0194525-B1 | N-CARBAMOYL-AZOLES AND FUNGICIDES CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1988-08-10 | — | — | EP | claimed |
| EP-0275077-A1 | Anthraquinone compounds and polarizing film containing the same | MITSUBISHI KASEI CORPORATION (JP) | 1988-07-20 | — | — | EP | claimed |
| EP-0269041-A2 | Fungicidal cyclohexylamines | BASF Aktiengesellschaft (DE) | 1988-06-01 | — | — | EP | claimed |
| EP-0243449-A1 | CYCLIC HYDROCARBONS WITH AN AMINOALKYL SIDECHAIN | THE UPJOHN COMPANY (US) | 1987-11-04 | — | — | EP | claimed |
| WO-1987002367-A2 | CYCLIC HYDROCARBONS WITH AN AMINOALKYL SIDECHAIN | THE UPJOHN COMPANY (US) | 1987-04-23 | — | — | WO | claimed |
| EP-0194525-A2 | N-Carbamoyl-azoles and fungicides containing them | BASF Aktiengesellschaft (DE) | 1986-09-17 | — | — | EP | claimed |
| US-4507221-A | Anthraquinone dye and liquid crystal composition containing the same | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1985-03-26 | — | — | US | claimed |
| EP-0120463-A2 | Anthraquinone dyes and liquid crystal compositions including the same | HITACHI, LTD. (JP) | 1984-10-03 | — | — | EP | claimed |
| US-4419263-A | Liquid crystalline cyclohexylcarbonitrile derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-12-06 | — | — | US | claimed |
| US-4324455-A | CONTAINING A QUINOPHTHALONE DYE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JP) | 1982-04-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176843-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | ALDH1A1 2356/4885SLC18A3 112/4885 |
| US-20060287303-A1 | Modulators of muscarinic receptors | CHRM3, CHRM5, CHRM2 | ALDH1A1 2356/4885SLC18A3 112/4885 |
| US-20100152176-A1 | Modulators of Muscarinic Receptors | CHRM3, CHRM5, CHRM2 | ALDH1A1 2356/4885SLC18A3 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.